Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.

Abstract

A series of naphthyl-based compounds were synthesized as potential inhibitors of vascular endothelial growth factor (VEGF) receptors. Investigations of structure-activity relationships led to the identification of a series of naphthamides that are potent inhibitors of the VEGF receptor tyrosine kinase family. Numerous analogues demonstrated low nanomolar inhibition of VEGF-dependent human umbilical vein endothelial cell (HUVEC) proliferation, and of these several compounds possessed favorable pharmacokinetic (PK) profiles. In particular, compound 48 demonstrated significant antitumor efficacy against established HT29 human colon adenocarcinoma xenografts implanted in athymic mice. A full account of the preparation, structure-activity relationships, pharmacokinetic properties, and pharmacology of analogues within this series is presented.

• Authors: Jean-Christophe Harmange, Matthew M Weiss, Julie Germain, Anthony J Polverino, George Borg, James Bready, Danlin Chen, Deborah Choquette, Angela Coxon, Tom DeMelfi, Lucian DiPietro, Nicholas Doerr, Juan Estrada, Julie Flynn, Russell F Graceffa, Shawn P Harriman, Stephen Kaufman, Daniel S La, Alexander Long, Matthew W Martin, Sesha Neervannan, Vinod F Patel, Michele Potashman, Kelly Regal, Phillip M Roveto, Michael L Schrag, Charlie Starnes, Andrew Tasker, Yohannes Teffera, Ling Wang, Ryan D White, Douglas A Whittington, Roger Zanon
• Journal: Journal of medicinal chemistry (J Med Chem) Vol. 51 Issue 6 Pg. 1649-67 (Mar 27 2008) ISSN: 0022-2623 [Print] United States
• PMID: 18324761 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Naphthalenes
• Protein Kinase Inhibitors
• Protein-Tyrosine Kinases
• Receptors, Vascular Endothelial Growth Factor

Topics

• Administration, Oral
• Animals
• Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
• Cell Line, Tumor
• Cell Proliferation (drug effects)
• Corneal Neovascularization (blood)
• Crystallography, X-Ray
• Dose-Response Relationship, Drug
• Drug Design
• Drug Evaluation, Preclinical
• Endothelial Cells (drug effects)
• Female
• Humans
• Inhibitory Concentration 50
• Injections, Intravenous
• Male
• Mice
• Mice, Inbred BALB C
• Mice, Nude
• Microsomes, Liver (drug effects)
• Models, Molecular
• Molecular Structure
• Naphthalenes (chemical synthesis, chemistry, pharmacology)
• Protein Kinase Inhibitors (chemical synthesis, chemistry, pharmacology)
• Protein-Tyrosine Kinases (antagonists & inhibitors)
• Rats
• Rats, Sprague-Dawley
• Receptors, Vascular Endothelial Growth Factor (antagonists & inhibitors)
• Reproducibility of Results
• Stereoisomerism
• Structure-Activity Relationship